Biotechnology

Complete Genomics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. The shares of common ...

BioCentric Energy Holdings, Inc. : Dennis Fisher, Founder and Chairman of the Board today announced contracts for algae derived products have been finalized.

The Board of Directors of PerkinElmer, Inc. , declared a regular quarterly dividend of $0.07 per share of common stock on July 30, 2010. This dividend is payable on November 12, 2010, to all shareholders of record at the close of business on ...

PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance ...

Lundbeck Inc. has voluntarily recalled two lots of NeoProfen Injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently available to prescribers and therefore the recall will result in a ...

Pharmasset, Inc. announces that management will present at the Wedbush Life Sciences Best Ideas: Management Access Conference being held on August 3, 2010 at the Le Parker Meridien, New York, NY and the Canaccord Genuity Global Growth Conference ...

Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.

Gilead Sciences, Inc. today announced the closing of its sale of $1.1 billion aggregate principal amount of 1.00% convertible senior notes due 2014 and $1.1 billion aggregate principal amount of 1.625% convertible senior notes due 2016 to qualified ...